# A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders

> **NCT04454684** · PHASE2 · WITHDRAWN · sponsor: **Resilient Pharmaceuticals**

## Conditions studied

- Anorexia Nervosa Restricting Type
- Binge-Eating Disorder

## Interventions

- **DRUG:** Midomafetamine
- **BEHAVIORAL:** Non-directive therapy
- **BEHAVIORAL:** Therapy

## Key facts

- **NCT ID:** NCT04454684
- **Lead sponsor:** Resilient Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-02
- **Primary completion:** 2028-08-10
- **Final completion:** 2028-08-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No site was initiated.
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04454684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04454684, "A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04454684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*